Literature DB >> 26336934

Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.

Ann Massie1, Séverine Boillée2, Sandra Hewett3, Lori Knackstedt4, Jan Lewerenz5.   

Abstract

System xc(-) is a cystine/glutamate antiporter that exchanges extracellular cystine for intracellular glutamate. Cystine is intracellularly reduced to cysteine, a building block of GSH. As such, system xc(-) can regulate the antioxidant capacity of cells. Moreover, in several brain regions, system xc(-) is the major source of extracellular glutamate. As such this antiporter is able to fulfill key physiological functions in the CNS, while evidence indicates it also plays a role in certain brain pathologies. Since the transcription of xCT, the specific subunit of system xc(-), is enhanced by the presence of reactive oxygen species and inflammatory cytokines, system xc(-) could be involved in toxic extracellular glutamate release in neurological disorders that are associated with increased oxidative stress and neuroinflammation. System xc(-) has also been reported to contribute to the invasiveness of brain tumors and, as a source of extracellular glutamate, could participate in the induction of peritumoral seizures. Two independent reviews (Pharmacol. Rev. 64, 2012, 780; Antioxid. Redox Signal. 18, 2013, 522), approached from a different perspective, have recently been published on the functions of system xc(-) in the CNS. In this review, we highlight novel achievements and insights covering the regulation of system xc(-) as well as its involvement in emotional behavior, cognition, addiction, neurological disorders and glioblastomas, acquired in the past few years. System xc(-) constitutes an important source of extrasynaptic glutamate in the brain. By modulating the tone of extrasynaptic metabotropic or ionotropic glutamate receptors, it affects excitatory neurotransmission, the threshold for overexcitation and excitotoxicity and, as a consequence, behavior. This review describes the current knowledge of how system xc(-) is regulated and involved in physiological as well as pathophysiological brain functioning.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  addiction; emotional and cognitive behavior; glioblastoma; glutamate; neurological disorders; system xc−

Mesh:

Substances:

Year:  2015        PMID: 26336934      PMCID: PMC4762049          DOI: 10.1111/jnc.13348

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  155 in total

1.  Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange.

Authors:  Z C Ye; J D Rothstein; H Sontheimer
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 2.  Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor.

Authors:  K Q Do; P L Herrling; P Streit; M Cuénod
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

Authors:  C Wahl; S Liptay; G Adler; R M Schmid
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Glutamate uptake is decreased tardively in the spinal cord of FALS mice.

Authors:  T Canton; J Pratt; J M Stutzmann; A Imperato; A Boireau
Journal:  Neuroreport       Date:  1998-03-30       Impact factor: 1.837

5.  Developmental change of endogenous glutamate and gamma-glutamyl transferase in cultured cerebral cortical interneurons and cerebellar granule cells, and in mouse cerebral cortex and cerebellum in vivo.

Authors:  E Kvamme; A Schousboe; L Hertz; I A Torgner; G Svenneby
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

6.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

7.  Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse.

Authors:  Khaled Moussawi; Wenhua Zhou; Haowei Shen; Carmela M Reichel; Ronald E See; David B Carr; Peter W Kalivas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 8.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

Authors:  Chrysanthy Ikonomidou; Lechoslaw Turski
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

9.  Molecular regulation of antioxidant ability in the hippocampus of EL mice.

Authors:  Mayuko Takaki; Yuto Ueda; Taku Doi; Keiko Nagatomo; Yoshiya L Murashima; Hiroshi Kannan
Journal:  Brain Res       Date:  2008-06-21       Impact factor: 3.252

10.  Autocrine glutamate signaling promotes glioma cell invasion.

Authors:  Susan A Lyons; W Joon Chung; Amy K Weaver; Toyin Ogunrinu; Harald Sontheimer
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

View more
  45 in total

Review 1.  Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies.

Authors:  Jennifer L McGuire; Laura B Ngwenya; Robert E McCullumsmith
Journal:  Mol Psychiatry       Date:  2018-09-13       Impact factor: 15.992

Review 2.  Genetic studies of alcohol dependence in the context of the addiction cycle.

Authors:  Matthew T Reilly; Antonio Noronha; David Goldman; George F Koob
Journal:  Neuropharmacology       Date:  2017-01-22       Impact factor: 5.250

Review 3.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

4.  Age and Alzheimer's disease gene expression profiles reversed by the glutamate modulator riluzole.

Authors:  A C Pereira; J D Gray; J F Kogan; R L Davidson; T G Rubin; M Okamoto; J H Morrison; B S McEwen
Journal:  Mol Psychiatry       Date:  2016-03-29       Impact factor: 15.992

Review 5.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Interleukin 1β Regulation of the System xc- Substrate-specific Subunit, xCT, in Primary Mouse Astrocytes Involves the RNA-binding Protein HuR.

Authors:  Jingxue Shi; Yan He; Sandra J Hewett; James A Hewett
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

7.  Chronic Sulfasalazine Treatment in Mice Induces System xc - - Independent Adverse Effects.

Authors:  Lise Verbruggen; Lindsay Sprimont; Eduard Bentea; Pauline Janssen; Azzedine Gharib; Lauren Deneyer; Laura De Pauw; Olaya Lara; Hideyo Sato; Charles Nicaise; Ann Massie
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

8.  Cystine-glutamate antiporter deletion accelerates motor recovery and improves histological outcomes following spinal cord injury in mice.

Authors:  Lindsay Sprimont; Pauline Janssen; Kathleen De Swert; Mathias Van Bulck; Ilse Rooman; Jacques Gilloteaux; Ann Massie; Charles Nicaise
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

Review 9.  Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior.

Authors:  Kathryn D Fischer; Lori A Knackstedt; Paul A Rosenberg
Journal:  Neurochem Int       Date:  2020-11-05       Impact factor: 3.921

10.  The Effects of N-Acetylcysteine on the Rat Mesocorticolimbic Pathway: Role of mGluR5 Receptors and Interaction with Ethanol.

Authors:  Sandra Fernández-Rodríguez; Claudia Esposito-Zapero; Teodoro Zornoza; Ana Polache; Luis Granero; María José Cano-Cebrián
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.